A Phase 2 Clinical Study of MM-151 in Patients with Colorectal Cancer

Trial Profile

A Phase 2 Clinical Study of MM-151 in Patients with Colorectal Cancer

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs MM-151 (Primary)
  • Indications Colorectal cancer; Solid tumours
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2015 Merrimack Pharmaceuticals anticipates to initiate this trial in 2015.
    • 22 May 2014 New trial record
    • 01 May 2014 According to a Merrimack Pharmaceuticals media release, a phase II clinical study for MM-151 will be initiated in 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top